The Latest Breaking News from PFE

Pfizer Pops on Q4 Results—But This May Be the Catalyst That Matters Most

Pfizer stock jumped after a strong earnings beat and positive GLP-1 data, but investors may be overlooking a powerful oncology and AI-driven growth story.

MarketBeat · Feb 5

Nasdaq Futures Climb on Blowout Palantir Results

March Nasdaq 100 E-Mini futures (NQH26) are trending up +0.41% this morning as forecast-beating quarterly results and guidance from Palantir Technologies boosted sentiment.

Barchart · Feb 3

What Are Wall Street Analysts' Target Price for Pfizer Stock?

Pfizer has lagged the broader market over the past year, and analysts remain cautious about its future outlook.

Barchart · Jan 27

Stocks Chop as the Unemployment Rate Jumps: Stock Market Today

November job growth was stronger than expected, but sharp losses in October and a rising unemployment rate are worrying market participants.

Kiplinger · Dec 16, 2025

Covered Call Screener Results For Dec 10th

Covered calls are a great strategy to add to any portfolio, and can offer enhanced yield from stock holdings, in some case, that can be a significant increase.

Barchart · Dec 11, 2025

How the EPP ushered in a right-wing majority at the European Parliament

For the first time, a right-wing majority is emerging at the European Parliament as the European People's Party flirts with groups that would have been considered too toxic to work with in the past. The pivot has given the EPP a choice but also created a headache for Ursula von…

Euronews · Nov 15, 2025

EPP teams up with far right to water down reporting requirements for companies

The European Parliament approved a package to ease corporate sustainability reporting and due diligence requirements. EPP teamed up with conservative and far-right MEPs to pass the law.

Euronews · Nov 13, 2025

Pfizer's Core Drugs Offset COVID Revenue Drop, Lifts 2025 Profit Outlook Despite Tariffs

On Tuesday, Pfizer Inc. (NYSE:PFE) reported third-quarter 2025 adjusted earnings of 87 cents, compared to $1.06 a year ago, beating the consensus of 63 cents.

Benzinga · Nov 4, 2025

Pfizer Stock: Is Wall Street Bullish or Bearish?

Pfizer has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart · Oct 29, 2025

Pfizer Seeks Expanded Use Approval For Breast Cancer Drug

Pfizer Inc. (NYSE:PFE) on Tuesday announced the initial results from a clinical trial called HER2CLIMB-05.  

Benzinga · Oct 14, 2025